Original Article

Prognostic Values of Inflammatory Markers in Patients with High-grade Lamina Propria-invasive Bladder Cancer

• İsmail Önder Yılmaz
• Mutlu Değer
• Nebil Akdoğan
• İbrahim Atilla Arıdoğan
• Yıldırım Bayazıt
• Volkan İzol

Review

The Risk Stratifications in Non-Muscle Invasive Bladder Cancer: How Much Accurate are the Methods That We Use? A Multi-Directional View

• Barış Kuzgunbay
• Yıldırım Bayazıt

Is intravesical BCG treatment necessary and/or sufficient?

• Sinan Ekici
• Polat Türker

Non-Muscle Invasive Bladder Cancer: Diagnosis and Treatment of Highest-Risk Subgroup

• Yılören Tanıdır
• İlker Tınay

Which Treatment Should We Prefer for High-Risk Nonmuscle Invasive Bladder Cancer? Early Cystectomy or Bladder Sparing?

• Ali Furkan Batur
• Sinan Sözen

The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guérin: What should Be the Treatment and Follow Up?

• Polat Türker
• Levent Türkeri

Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis of Patients with Non-Muscle Invasive Bladder Cancer: A Review Based on Meta-Analysis

• Emre Tüzel

Original Articles

Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer

• Zeliha Ertürk
• Esra Büber
• Haluk Özen
• Ömür Çelikbıçak
• Bekir Salih
• N. Leyla Açan

Review

Non-muscle Invasive Bladder Cancer: Identifying Patients to Consider Timely, Initial Cystectomy

• George E. Koch
• Sam S. Chang